Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

1.35
Delayed Data
As of 4:00pm ET
 -0.05 / -3.57%
Today’s Change
0.80
Today|||52-Week Range
3.48
+2.27%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close1.40
Today’s open1.36
Day’s range1.31 - 1.43
Volume115,462
Average volume (3 months)246,440
Market cap$35.6M
Dividend yield--
Data as of 4:00pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)+13.67%
Earnings growth (this year)+40.42%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.83

Competitors

 Today’s
change
Today’s
% change
THLDThreshold Pharmaceut...+0.03+6.23%
PRPHProPhase Labs Inc-0.03-1.40%
DMPIDelMar Pharmaceutica...-0.07-2.08%
NVLSNivalis Therapeutics...+0.03+1.35%
Data as of 4:00pm ET, 01/17/2017

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$29.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Joseph S. Podolski
Secretary, Chief Financial &
Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts


Search for Jobs